These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26806677)

  • 1. Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants.
    Silva ML; Perrier L; Paget JW; Mosnier A; Buthion V; Cohen JM; Späth HM
    Health Policy; 2016 Mar; 120(3):293-305. PubMed ID: 26806677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Seasonal Influenza Vaccination Recommendations: Relevance and Influence of the Evidence on the Decision-Making Process in France and the Netherlands.
    Silva ML; Paget WJ; Mosnier A; Buthion V; Cohen JM; Perrier L; Späth HM
    Value Health; 2016; 19(5):670-9. PubMed ID: 27565285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives.
    Bell S; Blanchard L; Walls H; Mounier-Jack S; Howard N
    Health Policy Plan; 2019 May; 34(4):271-281. PubMed ID: 31074778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
    Ba-Nguz A; Shah A; Bresee JS; Lafond KE; Cavallaro K; Shefer A; Donadel M; Seward JF
    Vaccine; 2019 Jun; 37(28):3646-3653. PubMed ID: 31130258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A literature review to identify factors that determine policies for influenza vaccination.
    Silva ML; Perrier L; Cohen JM; Paget WJ; Mosnier A; Späth HM
    Health Policy; 2015 Jun; 119(6):697-708. PubMed ID: 25936267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of NITAG policies and working processes in selected developed countries.
    Ricciardi GW; Toumi M; Weil-Olivier C; Ruitenberg EJ; Dankó D; Duru G; Picazo J; Zöllner Y; Poland G; Drummond M
    Vaccine; 2015 Jan; 33(1):3-11. PubMed ID: 25258100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda.
    Howard N; Walls H; Bell S; Mounier-Jack S
    Vaccine; 2018 Sep; 36(37):5536-5543. PubMed ID: 30076103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
    Dawa J; Chaves SS; Ba Nguz A; Kalani R; Anyango E; Mutie D; Muthoka P; Tabu C; Maritim M; Amukoye E; Were F;
    Vaccine; 2019 Jan; 37(3):464-472. PubMed ID: 30502070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.
    Adjagba A; Senouci K; Biellik R; Batmunkh N; Faye PC; Durupt A; Gessner BD; da Silva A
    Vaccine; 2015 Jan; 33(5):588-95. PubMed ID: 25545597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of National Immunization Technical Advisory Groups (NITAG) in strengthening health system governance: Lessons from three middle-income countries-Argentina, Jordan, and South Africa (2017-2018).
    Panero MS; Khuri-Bulos N; Biscayart C; Bonvehí P; Hayajneh W; Madhi SA
    Vaccine; 2020 Oct; 38(45):7118-7128. PubMed ID: 32950303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014.
    Perronne C; Adjagba A; Duclos P; Floret D; Houweling H; Le Goaster C; Lévy-Brühl D; Meyer F; Senouci K; Wichmann O
    Vaccine; 2016 Mar; 34(11):1325-30. PubMed ID: 26859237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Advisory Groups and their role in immunization policy-making processes in European countries.
    Nohynek H; Wichmann O; D Ancona F;
    Clin Microbiol Infect; 2013 Dec; 19(12):1096-105. PubMed ID: 23957860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengthening and sustainability of national immunization technical advisory groups (NITAGs) globally: Lessons and recommendations from the founding meeting of the global NITAG network.
    Adjagba A; MacDonald NE; Ortega-Pérez I; Duclos P;
    Vaccine; 2017 May; 35(23):3007-3011. PubMed ID: 28456526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups.
    Chocarro L; Duclos P; Senouci K; Southern J
    Expert Rev Vaccines; 2011 Sep; 10(9):1265-70. PubMed ID: 21919616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).
    Kahn AL; Steffen CA; Henaff L; MacDonald NE; Morgan C; Faden R; Olayinka F; Desai S
    Vaccine; 2023 Jan; 41(3):676-683. PubMed ID: 36494252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National malaria vector control policy: an analysis of the decision to scale-up larviciding in Nigeria.
    Tesfazghi K; Hill J; Jones C; Ranson H; Worrall E
    Health Policy Plan; 2016 Feb; 31(1):91-101. PubMed ID: 26082391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries.
    Howard N; Bell S; Walls H; Blanchard L; Brenzel L; Jit M; Mounier-Jack S
    Hum Vaccin Immunother; 2018 Jun; 14(6):1539-1541. PubMed ID: 29470931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Governing off-label vaccine use: An environmental scan of the Global National Immunization Technical Advisory Group Network.
    Top KA; Esteghamati A; Kervin M; Henaff L; Graham JE; MacDonald NE
    Vaccine; 2020 Jan; 38(5):1089-1095. PubMed ID: 31786003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
    Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
    Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012.
    Duclos P; Dumolard L; Abeysinghe N; Adjagba A; Janusz CB; Mihigo R; Mosina L; Takashima Y; Oztürk MH
    Vaccine; 2013 Nov; 31(46):5314-20. PubMed ID: 24055304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.